Chao Yang - The Fourth Hospital, Hebei Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase II Trial Comparing Dalpiciclib in Combination with Letrozole Versus Standard Chemotherapy As Neoadjuvant Therapy in Patients with High-Risk HR- Positive HER-2 Negative Breast Cancer: DARLING-02

Lina Zhang,Cuizhi Geng,Yueping Liu,Jianjun Han, Meng Han, Ruixue Huang,Xianqiao Li,Ruizhen Luo,Yuntao Li, Jie Ma,Huaihua Qi,Zunyi Wang, Xiaochun Wang,Chao Yang, Jingqiang Yang,Lixian Yang,Jingjing Yu,Yingzhou Zhang,Zhisheng Zhang,Xinping Zhou

Journal of Clinical Oncologyno. 16_suppl (2024): TPS626-TPS626

引用0浏览0引用

CDK4/6 Inhibitor Dalpiciclib Combined with Letrozole As Neoadjuvant Therapy in Postmenopausal Patients with Hormone Receptor- Positive, HER2-negative Stage II-III Breast Cancer: a Single-Arm Exploratory Trial

Lina Zhang,Chao Yang, Jie Ma,Yuntao Li, Ruizhen Luo, Jianjun Han, Xiaochun Wang, Zhisheng Zhang,Li Ma, Haifeng Cai,Xiangshun Kong, Zunyi Wang,Xinping Zhou,Yueping Liu, JiaJie Shi,Yanshou Zhang,Meiqi Wang,Jiaxing Wang, Cuizhi Geng

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Adjuvant Chemotherapy and Survival Outcomes in Older Women with HR+/HER2− Breast Cancer: a Propensity Score-Matched Retrospective Cohort Study Using the SEER Database

Xindi Ma,Shang Wu,Xiangmei Zhang,Nannan Chen,Chenhui Yang,Chao Yang,Miao Cao,Kaiye Du,Yunjiang Liu

BMJ Openno. 3 (2024): e078782-e078782

引用0浏览0WOS引用

Changes in HER2 Status and Survival Outcomes in Patients with Non-Pathological Complete Response after Neoadjuvant Targeted Treatment

Xiaofei Ren,Xiangmei Zhang,Xiangmin Ma,Chao Yang,Jingping Li,Beichen Liu,Chao Shi,Yunjiang Liu

Medicineno. 39 (2023): e34903-e34903

引用0浏览0WOS引用

A nomogram for predicting prognosis of internal mammary lymph node metastasis in breast cancer patients with neoadjuvant chemotherapy

Jinzhao Liu,Wei-Fang Zhang,Yi-Fei Li,Guo-Zhong Cui,Chao Yang,Geng Zhang, Shuo Zhang,Xiang-Mei Zhang,Yun-Jiang Liu

Research Square (Research Square) (2022)

引用0浏览0引用

Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer Via Mir-200B-3p/anln

Chao Yang,Liang Liu,Chao Gao,Geng Zhang,Yanshou Zhang,Shuo Zhang,Jingping Li,Yunjiang Liu

JOURNAL OF SURGICAL RESEARCH（2022）

引用2浏览0WOS引用

Metastasis Patterns and Prognosis in Young Breast Cancer Patients: A SEER Database Analysis

Weifang Zhang,Shang Wu,Jinzhao Liu,Xiangmei Zhang,Xindi Ma,Chao Yang,Miao Cao,Shuo Zhang,Yunjiang Liu

FRONTIERS IN ONCOLOGY（2022）

引用3浏览0引用

NRBP1 Negatively Regulates SALL4 to Reduce the Invasion and Migration, Promote Apoptosis and Increase the Sensitivity to Chemotherapy Drugs of Breast Cancer Cells

Chao Yang,Xiangmei Zhang,Chao Gao,Kaiye Du,Yunjiang Liu

Oncology Letters（2022）

引用2浏览0WOS引用

The Prognostic Role of Lymph Node Ratio in Breast Cancer Patients Received Neoadjuvant Chemotherapy: A Dose-Response Meta-Analysis

Jinzhao Liu,Yifei Li,Weifang Zhang, Chunliang Yang,Chao Yang,Liang Chen,Mingjian Ding,Liang Zhang, Xiaojun Liu,Guozhong Cui,Yunjiang Liu

Frontiers in surgery (2022)

引用2浏览0引用

Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring

Jiayi Yin,Shiming Zhang,Chao Yang,Yan Wang,Bing Shi,Qian Zheng,Ni Zeng,Hanyao Huang

Front Immunol（2022）

引用11浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn